Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023 at 05:05 AM EDT
Roivant Sciences has 12 drugs in its pipeline. The company’s Immunovant subsidiary reported strong results for its drug. Roivant is in talks with Roche to sell its Chron’s disease for $7 billion.
